Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075243 · ClinicalTrials.gov registry record · Phase 4
Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic Efficacy
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 401
- Enrollment target
NCT01075243 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 401 participants.
The verdict
NCT01075243, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 401 participants
- Enrollment target
Study Summary
GlaxoSmithKline will be conducting this trial to compare analgesic efficacy of paracetamol 1000 mg vs 650 mg. The post-surgical dental pain model will be used to evaluate the analgesic efficacy of paracetamol. Each subject will be enrolled in the study for up to six weeks. The duration of the entire study will be approximately 18 weeks. Each subject will have to come to the clinic for three visits (Screening, Treatment and Follow up visits).
Interventions
- DRUG Placebo
- DRUG Paracetamol 1000 mg
- DRUG Paracetamol 650 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01075243
The ClinicalTrials.gov registry entry for NCT01075243 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01075243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01075243 about?
NCT01075243 is a clinical study titled "Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic Efficacy". GlaxoSmithKline will be conducting this trial to compare analgesic efficacy of paracetamol 1000 mg vs 650 mg. The post-surgical dental pain model will be used to evaluate the analgesic efficacy of paracetamol. Each subject will be enrolled in the study for up to six weeks. The duration of the entire...
What is the current status of trial NCT01075243?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 401 participants. The study started on 2009-11. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01075243?
The interventions under investigation include: Placebo (DRUG), Paracetamol 1000 mg (DRUG), Paracetamol 650 mg (DRUG).
Who is sponsoring clinical trial NCT01075243?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.